Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Karyotypic evolution in B-cell chronic lymphocytic leukaemia.

D Oscier1, M Fitchett, T Herbert

  • 1Department of Haematology, Royal Victoria Hospital, Bournemouth, England.

Genes, Chromosomes & Cancer
|January 1, 1991
PubMed
Summary

Karyotypic evolution in chronic lymphocytic leukemia (CLL) occurred in 16% of patients. Disease progression did not significantly differ between stable and evolving karyotypes, suggesting limited clinical impact of karyotypic changes in B-CLL.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

EGR2 mutations define a new clinically aggressive subgroup of chronic lymphocytic leukemia.

Leukemia·2016
Same author

Cytogenetic Findings and Survival in B-cell Chronic Lymphocytic Leukemia. Second IWCCLL Compilation of Data on 662 Patients.

Leukemia & lymphoma·2016
Same author

The SF3B1 inhibitor spliceostatin A (SSA) elicits apoptosis in chronic lymphocytic leukaemia cells through downregulation of Mcl-1.

Leukemia·2015
Same author

KLF2 mutation is the most frequent somatic change in splenic marginal zone lymphoma and identifies a subset with distinct genotype.

Leukemia·2014
Same author

Recurrent mutations refine prognosis in chronic lymphocytic leukemia.

Leukemia·2014
Same author

Whole-exome sequencing in splenic marginal zone lymphoma reveals mutations in genes involved in marginal zone differentiation.

Leukemia·2013

Area of Science:

  • Hematology
  • Oncology
  • Cytogenetics

Background:

  • B-cell chronic lymphocytic leukemia (B-CLL) is a heterogeneous lymphoid malignancy.
  • Cytogenetic abnormalities are crucial for B-CLL prognostication and understanding disease evolution.

Purpose of the Study:

  • To investigate the occurrence and clinical significance of karyotypic evolution in B-CLL patients.
  • To assess the relationship between karyotypic changes and disease progression.

Main Methods:

  • Sequential cytogenetic analysis of peripheral blood leucocytes.
  • Analysis of karyotypes in 112 B-CLL patients over multiple sampling occasions (mean 3.6).
  • Comparison of disease progression rates between patients with stable vs. evolving karyotypes.

Related Experiment Videos

Main Results:

  • Karyotypic evolution was observed in 18 out of 112 patients (16%).
  • No significant difference in disease progression was found between patients with stable karyotypes and those with karyotypic evolution.
  • A clear association between disease progression, altered cell morphology, and karyotypic evolution was identified in only one patient.

Conclusions:

  • Karyotypic evolution occurs in a subset of B-CLL patients but may not significantly impact overall disease progression.
  • The clinical relevance of karyotypic evolution in B-CLL warrants further investigation.
  • Cytogenetic stability does not preclude disease progression in B-CLL.